Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05025670 · ClinicalTrials.gov registry record
Tracking Response in Advance of Investigational Trials, Borderline Study
A clinical trial, sponsored by Adams Clinical.
- Completed
- Registry status
- 28
- Enrollment target
NCT05025670: Completed study, sponsored by Adams Clinical.
NCT05025670 is a clinical trial that has completed, run by Adams Clinical. The registered enrollment target is 28 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05025670 has completed, sponsored by Adams Clinical.
- COMPLETED
- Registry status
- 28 participants
- Enrollment target
Study Summary
TRAIT-BOR is an open-label psychotherapy treatment study for adults who meet the diagnostic criteria for Borderline Personality Disorder (BPD) and are seeking enrollment in a clinical trial of a novel compound to treat BPD. The current study seeks to determine if there are therapeutic benefits to more infrequent, short term, or longer term supportive psychotherapy.
Primary Outcome
Total scores on the AAPI-CR range from 11 to 275, with higher scores indicating higher levels of agitation and aggression.
Interventions
- BEHAVIORAL Supportive psychotherapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2021-08-05 |
| Est. Completion | 2022-12-15 |
What the finished NCT05025670 record still lists
NCT05025670 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 28 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Supportive psychotherapy is the first listed.
NCT05025670 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05025670 about?
NCT05025670 is a clinical study titled "Tracking Response in Advance of Investigational Trials, Borderline Study". TRAIT-BOR is an open-label psychotherapy treatment study for adults who meet the diagnostic criteria for Borderline Personality Disorder (BPD) and are seeking enrollment in a clinical trial of a novel compound to treat BPD. The current study seeks to determine if there are therapeutic benefits to mo...
What is the current status of trial NCT05025670?
This trial is currently completed. The enrollment target is 28 participants. The study started on 2021-08-05. Estimated completion is 2022-12-15.
What interventions are being tested in trial NCT05025670?
The interventions under investigation include: Supportive psychotherapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT05025670?
This trial is sponsored by Adams Clinical, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03471117 · 28 participants · Phase 4
Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients
- NCT03523975 · 28 participants · Phase 1
Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma
- NCT03608631 · 28 participants · Phase 1
iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation
- NCT03810651 · 28 participants · Early Phase 1
Pencil Beam Scanning in Patients With Renal Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI